Statistics Act, 1999
R 385
Mine Health and Safety Act, 1996 (Act No. 29 of 1996)NoticesGuidance Note for a Management and Control Programme for Tuberculosis in the South African Mining IndustryPart B : Author's Guide6. Treatment regimens |
These should be strictly as recommended in the NTBMG (as set out below).
|
REGIMEN 1: For new patients and previously treated |
|||
|
Pre-treatment body weight |
Intensive Phase 7 days a week for 2 months |
Continuation phase 7 days a week for 4 months |
|
|
RHZE (150,75,400,275) |
RH (150,75) |
RH (300,150) |
|
|
30-37 kg |
2 tabs |
2 tabs |
|
|
38-54 kg |
3 tabs |
3 tabs |
|
|
|
4 tabs |
|
2 tabs |
|
>70kg |
5 tabs |
2 tabs |
|
| NOTE: | Where NAT is used and the result is Rifampicin susceptible then Regimen 1 should be used for both new and previously treated patients. Where the NAT result is Rifampicin resistant, the patient should be started on MDR-TB treatment. All Rifampicin resistant patients should have a culture and first line DST conducted to confirm MDR-TB. The dosages may be adjusted based on changes in weight. |
